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Amanda Díaz-García a,*, Alberto González-Robles a, Azucena García-Palacios b,c, 
Isabel Fernández-Felipe b, Cintia Tur b, Diana Castilla c,d, Cristina Botella b,c 
a Department of Psychology and Sociology, Universidad de Zaragoza (Campus de Teruel), Teruel, Spain 
b Department of Basic and Clinical Psychology, and Psychobiology, Universitat Jaume I, Castellon, Spain 
c CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain 
d Department of Personality, Evaluation and Psychological Treatments, Universidad de Valencia, Valencia, Spain   









A B S T R A C T   
Introduction: Emotional disorders (anxiety and depressive disorders) are a relevant public health concern asso-
ciated with high prevalence, high costs, and important disability. Therefore, research priorities include designing 
and testing cost-effective interventions to reach everyone in need. Internet-delivered interventions for emotional 
disorders are effective and can help to disseminate and implement evidence-based treatments. However, 
although these treatments are generally effective, not all patients benefit from this treatment format equally. 
Blended treatments are a new form of intervention that combines the strengths of face-to-face and Internet 
approaches. Nevertheless, research on blended interventions has focused primarily on individual therapy, and 
less attention has been paid to the potential of using this format in group psychotherapy. This study aims to 
analyze the feasibility of blended transdiagnostic group CBT for emotional disorders. The current article de-
scribes the study protocol for this trial. 
Method and analysis: A one-armed pilot trial will be conducted. Participants will be 30 adults suffering from DSM- 
5 anxiety and/or depressive disorders. The treatment consists of a blended transdiagnostic group intervention 
delivered during a period of 24 weeks. Groups of 6 to 10 patients will attend a total of eight 2-hour, face-to-face 
sessions, alternated with the use of an online platform where they will find the contents of the treatment pro-
tocol. The intervention has four core components: present-focused awareness, cognitive flexibility, identification 
and modification of behavioral and cognitive patterns of emotional avoidance, and interoceptive and situational 
exposure. These components are delivered in 16 modules. Assessments will be performed at baseline, during the 
treatment, at post-treatment, and at 3-month follow-up. Clinical and treatment acceptability outcomes will be 
included. Quantitative and qualitative data (participants’ views about blended group psychotherapy) will be 
analyzed. 
Ethics and dissemination: The trial has received ethical approval from the Ethics Committee of Universitat Jaume I 
(September 2019) and will be conducted in accordance with the study protocol, the Declaration of Helsinki, and 
good clinical practice. The results of this study will be disseminated by presentation at conferences and will be 
submitted for publication in a peer-reviewed journal. 
Trial registration: ClinicalTrials.gov Identifier: NCT04008576. Registered 05 July 2019, https://clinicaltrials. 
gov/ct2/show/NCT04008576   
1. Introduction 
Emotional disorders (anxiety and depressive disorders) (Bullis et al., 
2019) are the most prevalent mental disorders (Ferrari et al., 2013; 
Kessler et al., 2005), and impact the lives of millions of people world-
wide (Kohn et al., 2004; Steel et al., 2014). Moreover, emotional dis-
orders are associated with high costs (Andlin-Sobocki and Wittchen, 
2005; Cuijpers et al., 2012), disability (Baxter et al., 2014), chronicity 
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(Richards, 2011), and high comorbidity rates with other emotional 
disorders (Kroenke et al., 2007). 
A large body of research shows the efficacy of cognitive-behavioral 
treatments (CBT) for emotional disorders (Nathan and Gorman, 2015). 
However, although there is little doubt about the efficacy and effec-
tiveness of CBT for emotional disorders, the dissemination and effective 
implementation of these protocols is still a major challenge for research 
and clinical practice (McHugh and Barlow, 2010). In other words, 
despite research efforts to provide empirically supported treatments 
during the past three decades, there is still an important treatment gap in 
mental healthcare, leading to a large proportion of patients who do not 
receive treatment in mental healthcare services, especially those with 
anxiety and mood disorders (Kohn et al., 2004; Lilienfeld et al., 2013; 
Wang et al., 2007). 
In the past two decades, different approaches have emerged to 
improve the dissemination and implementation of evidence-based 
treatments. In this regard, one important line of research is the trans-
diagnostic approach to the treatment of emotional disorders. The effi-
cacy of transdiagnostic treatments has been shown in a growing number 
of meta-analytic studies (García-Escalera et al., 2016; Newby et al., 
2015, 2016; Reinholt and Krogh, 2014). The main defining character-
istic of transdiagnostic treatments is that they “apply the same under-
lying treatment principles across mental disorders, without tailoring the 
protocol to specific diagnoses” (McManus et al., 2010, p. 4). Broadly, 
transdiagnostic treatments are based on the premise that the common-
alities of psychological disorders outweigh their differences, and that the 
observed differences (symptoms) are specific manifestations of broader, 
underlying common psychopathological processes. This approach has 
been called the “mechanistically transdiagnostic approach”, and it has 
fueled the development of transdiagnostic treatments based on “shared 
mechanisms” (Sauer-Zavala et al., 2017). For these reasons, the use of 
transdiagnostic treatments has important implications for clinical 
practice. For example, comorbid presentations can be targeted more 
appropriately (Mansell et al., 2008), and training costs are lower 
because clinicians only have to be trained in one protocol instead of 
different protocols for each specific diagnosis (McEvoy et al., 2009).The 
goal of these treatments has typically been to train the individual in 
emotion regulation strategies to address the dimension of neuroticism or 
negative affect (Barlow et al., 2004; Norton, 2012; Titov et al., 2010, 
2011). However, the interest in directly targeting positive affect in the 
context of emotional disorders has increased in more recent research 
(Carl et al., 2018; Taylor et al., 2017). For instance, Carl et al. (2018) 
proposed a module for the regulation of positive affectivity to be applied 
transdiagnostically across anxiety and depressive disorders. According 
to the authors, the module can be implemented flexibly, either inte-
grated into a modular treatment program (e.g., the Unified Protocol) or 
as an adjunct treatment for patients who show deficits in positive affect 
at post-treatment. 
Another approach that could enhance the dissemination and imple-
mentation of evidence-based CBT and considerably reduce the costs is 
the use of the Internet to deliver treatments. A number of systematic 
reviews have shown that Internet-delivered treatments for depression 
and anxiety disorders are more effective than different control groups, 
such as waitlist and treatment as usual groups (Andrews et al., 2018; 
Richards and Richardson, 2012; Spek et al., 2007), and that they work as 
effectively as face-to-face psychotherapy (Carlbring et al., 2018). In the 
context of Internet-delivered treatments, one possibility consists of the 
so-called “blended treatments”, that is, the combination of face-to-face 
and Internet-delivered therapy (Kleiboer et al., 2016; Kooistra et al., 
2014). Some of the advantages of these interventions include enhancing 
the learning process (e.g., retention of learned information or 
improvement of learned tasks), extending the reach of information by 
using the Internet, and optimizing development costs and time and cost- 
effectiveness (i.e., to offer learning strategies that reach large numbers 
of individuals quickly) (Cucciare et al., 2008). Moreover, by partici-
pating in a blended treatment, patients can work on their own mental 
health between sessions, increasing their ability to adapt and self- 
manage, which are core aspects in defining health (Huber et al., 
2011). There is growing support in the literature for the claim that 
blended therapy may save clinician time, lead to lower dropout rates, 
help maintain the effects of inpatient therapy, and increase the effects of 
psychotherapy, compared to stand-alone face-to-face therapy (Erbe 
et al., 2017). Thus, another advantage of blended treatments is their 
lower cost in comparison with traditional face-to-face psychotherapy, 
suggesting that this treatment delivery format can help to save therapist 
time. For instance, the usual treatments include between 12 and 14 
sessions, whereas blended treatments are shortened to 6–8 sessions, 
representing a 33–57% savings in terms of costs and time (Schuster 
et al., 2018). Furthermore, blended treatments might be a good alter-
native for those patients who are less likely to benefit from guided or 
unguided Internet-delivered treatments (with no face-to-face contact). 
Another way to reduce the costs of psychotherapy is through the use of 
the group format. The literature has shown that, for the treatment of 
anxiety and depressive disorders, different methods of implementation 
(individual vs. group CBT) have led to similar drop-out rates or satis-
faction with the treatment (Bastien et al., 2004; Jónsson et al., 2011). 
Numerous advantages have been attributed to group therapy, such as 
support (the group become a valuable source of support), confidentiality 
(one of the ground rules for group therapy), or diversity (it makes it 
possible to discover a whole range of strategies to face problems) (APA, 
2013; Sepúlveda et al., 2010). In addition, as the National Institute for 
Health and Care Excellence recommends, group CBT should be consid-
ered for people with mild to moderate depression who decline low- 
intensity psychosocial interventions such as Internet-based treatments 
(NIH, 2009). Furthermore, the literature suggests that the two treatment 
formats (individual vs. group) are comparable in terms of rates of 
treatment acceptance, dropout, remission, or improvement (Barkowski 
et al., 2016). Therefore, group therapy is an appropriate strategy to 
reduce the burden of these disorders in a more cost-effective manner. 
A treatment strategy that may boost the cost-effectiveness relation-
ship is the combination of the blended and group formats. In spite of the 
advantages of group CBT, in the specific field of transdiagnostic treat-
ments, research has mainly focused on individual transdiagnostic 
treatments (González-Robles et al., 2018a, 2018b), with some excep-
tions (Norton, 2012; Reinholt et al., 2017). In Spain, Osma et al. (2019) 
are conducting arandomized controlled trial (RCT) that tests trans-
diagnostic group psychotherapy in specialized mental health care. 
However, to our knowledge, no studies have been published that 
combine blended (i.e., face-to-face plus Internet-delivered psychother-
apy) and group delivery formats to provide transdiagnostic treatments 
for emotional disorders. The existing studies on blended group psy-
chotherapy are quite scarce, and they focus only on the treatment of 
major depressive disorder (Schuster et al., 2018). Combining these two 
treatment approaches to deliver a transdiagnostic treatment might be a 
highly cost-effective treatment strategy for these disorders, which could 
ultimately contribute to the dissemination and implementation of 
evidence-based transdiagnostic CBT. 
1.1. Current study 
The objective of this study is to analyze the feasibility of blended 
transdiagnostic group CBT for emotional disorders. To this end, a 
transdiagnostic Internet-delivered treatment protocol will be delivered 
in combination with group psychotherapy sessions. The treatment pro-
tocol is a mechanistically transdiagnostic treatment that adds a specific 
component for the regulation of positive affectivity. Thus, the treatment 
contains strategies for the regulation of both negative affectivity and 
positive affectivity. The manualized version of this treatment protocol 
has already been pilot-tested in an individual face-to-face format 
(González-Robles et al., 2019), and results of a randomized controlled 
trial of the Internet-delivered version have already been published 
(González-Robles et al., 2020). Specifically, we aim to study the 
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adequacy of the different methods of recruitment and data collection (e. 
g., how broad or restrictive eligibility criteria are, how willing patients 
are to participate, time needed to collect data), to explore reasons for 
non-participation and for dropping out from the treatment, to analyze 
and select optimal outcome measures, and to explore patients’ accept-
ability of the intervention (both quantitatively and qualitatively). 
Furthermore, a secondary aim of the study is to preliminary estimate the 
impact of the intervention at post-treatment and 3-month follow up. 
These objectives will help to optimize the design of a future RCT and 
they are consistent with the recommendations found in the literature 
about feasibility studies (Eldridge et al., 2013, 2016). The current article 
describes the study protocol of this trial. 
2. Method and analysis 
2.1. Design 
The current study uses a single-group, open-trial design with three 
measurement points: baseline (pre-treatment), immediately after the 
intervention (post-treatment), and at 3-month follow-up. A mixed- 
method design will be used (including quantitative and qualitative 
methodology) (Creswell and Clark, 2017), in line with guidelines for 
Good Reporting of a Mixed Method Study (O’cathain et al., 2008) and 
for complex interventions (Craig et al., 2008).This design is appropriate 
to evaluate an intervention before it is introduced in a clinical setting 
(Bowen et al., 2009). Quantitative data will be collected through the 
online platform using validated questionnaires. Qualitative data will be 
collected using the focus group method using in-depth questions. 
Quantitative data will be employed to explore changes in outcomes, 
while qualitative data will provide data on the participants’ opinions 
about the treatment, the face-to-face sessions, and the online platform. 
2.2. Participants, recruitment and procedure 
Participants will be adults attending the Service of Psychological 
Assistance at Universitat Jaume I to seek psychological help. The main 
aim of this service is to provide evidence-based treatment protocols 
using Information and communication Technologies tools. After an 
initial screening session, an additional session will be arranged with 
those candidates interested in participating to confirm that they meet 
the eligibility diagnostic criteria, using the MINI International Neuro-
psychiatric Interview (MINI) (Ferrando et al., 1997; Sheehan et al., 
1998). This session will be used to collect sociodemographic and other 
clinical data (e.g., medication). Moreover, patients will be asked about 
medication types and dose before starting the intervention, and these 
data will be monitored and recorded during the treatment and follow-up 
periods. Once the characteristics of the study have been explained to 
participants, they will be asked to sign an informed, written consent 
form. All the assessment instruments will be delivered through a web 
platform (https://www.psicologiaytecnologia.labpsitec.es), and assess-
ments will take place at pre- and post-treatment and at 3-month follow- 
up. One week before the intervention starts (i.e., first group session), 
patients will be asked to complete pre-treatment assessment in-
struments. Post-treatment questionnaires will be completed 3 weeks 
after the last group session. 
Groups will be led by two trained therapists (AD-G and AG-R), each 
of whom will have the support of a co-therapist (IF-F and CT). Both 
therapists and co-therapists are qualified clinicians with experience in 
the treatment of emotional disorders and have been trained in the use of 
the transdiagnostic treatment protocol as well as the study protocol. 
Moreover, the leading therapists (AD-G and AG-R) developed doctoral 
dissertations focused on the application of transdiagnostic CBT (Díaz- 
García et al., 2017; González-Robles et al., 2020). All the therapists have 
experience with group psychotherapy, and they will be supervised by 
expert clinicians with extensive experience in the application of 
evidence-based CBT and this transdiagnostic protocol for emotional 
disorders. All the therapists involved in participant assessments have 
already been trained in the use of the diagnostic interview (i.e., MINI). 
The study flowchart is shown in Fig. 1. 
The study has been registered in Clinicaltrials.gov (https://clinicaltr 
ials.gov/) as NCT04008576 (https://clinicaltrials.gov/ct2/show/NC 
T04008576) and received ethical approval from the Ethics Committee 
of Universitat Jaume I (Castellon, Spain). 
Because the study is designed to assess the feasibility of conducting 
an RCT, a formal power calculation is not considered appropriate. A 
minimum of 30 participants is considered enough to cover the aims of 
this feasibility study and to provide data about a number of parameters 
(i.e., adherence, attrition, satisfaction with the online treatment and 
with the face-to-face group sessions, deterioration rate, platform usage, 
and so on) that will help to optimize the future RCT design. 
2.3. Eligibility criteria 
The selection of participants will be based on the following eligibility 
criteria: a) age 18 years old or older; b) fluency in Spanish; c) daily 
access to the Internet at home and an email address; d) meeting DSM-5 
diagnostic criteria (DSM-5 American Psychological Association, 2013) 
for at least one of the following emotional disorders (Bullis et al., 2019): 
major depressive disorder, dysthymic disorder, other specified/un-
specified depressive disorder, panic disorder, agoraphobia, social anxi-
ety disorder, generalized anxiety disorder, other specified/unspecified 
anxiety disorder, and obsessive-compulsive disorder; e) absence of 
schizophrenia, bipolar disorder and/or alcohol and/or substance 
dependence disorder; f) absence of high suicide risk; g) not receiving any 
additional psychological treatment during the study period; and h) no 
changes and/or increases in pharmacological treatment during the 
treatment and follow-up periods (decreases in medication will be 
accepted). 
2.4. Treatment 
The treatment consists of a blended transdiagnostic group inter-
vention delivered during a period of 24 weeks. Groups of 6 to 10 patients 
will attend a total of eight 2-hour, face-to-face sessions, alternated with 
the use of an online platform where they will find the contents of the 
treatment protocol. The treatment is a 16-module transdiagnostic CBT 
Internet-delivered protocol adapted from the Unified Protocol (Barlow 
et al., 2011a, 2011b) and treatment strategies derived from Dialectical 
Behavioral Therapy (Linehan, 1993). The treatment was initially 
developed and structured in a patient and therapist handbook (Botella 
et al. Transdiagnostic Treatment for Emotion Disorders: Manualized 
Treatment Protocol, unpublished) and, later, adapted to a multimedia 
web platform designed by our research group (https://www.psicolo 
giaytecnologia.labpsitec.es). The intervention has four core compo-
nents that aim to: a) increase present-focused awareness, b) promote 
cognitive flexibility, c) identify and modify behavioral and cognitive 
patterns of emotional avoidance, and d) promote interoceptive and 
situational graded exposure. Additionally, it also contains a treatment 
component aimed at regulating positive affect (modules 12 to 15). These 
components are preceded by three modules containing psychoeducation 
about emotions and emotion regulation, and a module to facilitate pa-
tients’ readiness to change (motivation for change) (modules 1 to 3), and 
they are followed by a relapse prevention module (module 16). More 
details about the online treatment platform and the contents of the 
modules have been published elsewhere (Díaz-García et al., 2017; 
González-Robles et al., 2019). 
Each group will meet once every three weeks. During the three weeks 
between group sessions, participants will be asked to access the online 
platform to review the treatment contents and do the homework tasks. 
Attendance of participants to the face-to-face sessions as well as program 
usage will be monitored throughout the whole study period. Overall, 
group sessions will be divided in two parts: the first part will focus on 
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discussing the contents of the modules already targeted, whereas the 
second part will be devoted to presenting the contents of the modules to 
be addressed in the following three weeks. In order to make the sessions 
more dynamic and appealing to patients, a practical and participative 
approach will be followed. The structure of the face-to-face group ses-
sions and the contents of the online modules are described in greater 
detail in Table 1. 
In order to promote the use of the online platform between the group 
sessions, all the participants will be sent two automatized emails (e.g., 
“We encourage you to review the modules and carry out all the tasks 
described in the program as many times as necessary. Remember, the 
more you practice, the more you will benefit from the treatment”) and 
two mobile phone text messages (e.g. “Hi there! Don’t give up on your 
module tasks! Dedicate some time and effort to them. Remember, 
practice makes perfect!”) once a week during the treatment period. In 
general, the purpose of these messages is to encourage the practice of the 
treatment strategies, increase the time the participants spend using the 
platform, and provide positive reinforcement. 
2.5. Outcome measures 
2.5.1. Clinical outcomes 
2.5.1.1. Diagnostic interview. Mini International Neuropsychiatric 
Interview Version 7.0.2 (MINI). It is a widely used structured diagnostic 
psychiatric interview to determine DSM-5 and ICD-10 diagnoses. This 
interview is a brief and accurate structured interview that can be 
administered by clinicians after a brief training session and in a short 
period of time. It can also be administered by nonclinical interviewers 
after more intensive training. The MINI has excellent test-retest and 
inter-rater reliability (k = 0.88–1.00) and adequate concurrent validity 
with the Composite International Diagnostic Interview (Lecrubier et al., 
1997). This interview has been translated and validated in Spanish 
(Ferrando et al., 1997). 
2.5.1.2. Primary outcomes measures. Overall Anxiety Severity and 
Impairment Scale (OASIS) (Campbell-Sills et al., 2009). The OASIS is a 
5-item questionnaire that assesses the severity and functional impair-
ment caused by anxiety symptoms during the previous week. Items are 
rated on a scale ranging from 0 to 4, added together to obtain a score 
that ranges between 0 and 20. Previous studies have shown good 
internal consistency (α = 0.80), test-retest reliability, and convergent 
and discriminant validity. The Spanish version has shown good internal 
consistency (α = 0.86) and construct validity in patients with emotional 
disorders (González-Robles et al., 2018a, 2018b). 
Overall Depression Severity and Impairment Scale (ODSIS) (Bentley 
et al., 2014). The ODSIS is a brief scale made up of 5 items for the 
assessment of the severity and impairment associated with depressive 
symptoms during the previous week. The responses are coded on a 5- 
point scale (0 to 4), and scores can range between 0 and 20 points. 
The instrument has demonstrated excellent internal consistency in 
different samples (α = 0.91 to 0.94) and good convergent and discrim-
inant validity. The Spanish validation has also shown excellent internal 
consistency (α = 0.93) and convergent and discriminant validity (Mira 
et al., 2019). 
2.5.1.3. Secondary outcomes measures. Positive and Negative Affect 
Schedule (PANAS) (Watson et al., 1988). The PANAS is a 20-item scale 
that assesses the dimensions of positive affectivity and negative affec-
tivity. The scale contains 10 descriptors for each dimension (e.g., 
“enthusiastic”, “inspired”, or “proud” in the positive affectivity scale; 
“scared”, “irritable”, or “guilty” in the negative affect scale). For each 
item, responses are rated on a 5-point scale (1–5), and the scores on each 
scale (10 items on each) can range from 10 to 50. The scale has shown 
excellent convergent and discriminant validity. The Spanish version has 
demonstrated good psychometric properties (Díaz-Garcia et al., 2020; 
Sandín et al., 1999). 
NEO-five factor Inventory (NEO-FFI) (Robins et al., 2001). The NEO- 
FFI is a shorter version of the NEO-PI-R composed of 60 items that 
evaluate the personality dimensions of the five-factor personality model 
(Costa and McCrae, 1992). Because this study is focused on a mecha-
nistically transdiagnostic treatment that emphasizes the dimensions of 
neuroticism and extraversion (McManus et al., 2010), only the scores in 
these dimensions will be used. The NEO-FFI has shown good test-retest 
reliability. The Spanish version of the questionnaire also showed good 
psychometric properties (Aluja et al., 2005). 
Quality of Life Index (QLI) (Mezzich et al., 1986). The QLI is a scale 
containing 10 items that assesses quality of life in the following ten 
areas: psychological well-being, physical well-being, emotional and so-
cial support, interpersonal functioning, self-care and independent 
functioning, community and service support, occupational functioning, 
self-realization, spiritual satisfaction, and an overall assessment of 
Fig. 1. Flowchart of participants.  
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Table 1 
Structure of face-to-face sessions and multimedia elements.  
Sessions Group session Modules Multimedia elements 
S1 Part 1 (45′):   
– Therapists’ introduction  
– Discussion of the advantages 
and rules of group therapy  
– Patients’ introduction 
Part 2 (75′):   
– Presentation of M1 to M3 
M1. Emotional disorders and 
emotion regulation 
M2. Motivation for change 
M3. Understanding the role of 
emotions 
Videos 1–5. Objectives of the module; the transdiagnostic approach; emotion regulation; 
contents of the program; the importance of homework tasks 
Videos 6–12. Examples of patients with different emotional disorders 
Multiple-choice check questions 
PDF1 questions for reflection 
PDF2 summary of M1  
Videos 1–6. Objectives of the module; ambivalence about change; identifying objectives and 
goals; pros and cons of changing (example); identifying objectives and goals (example); the 
importance of homework tasks 
Multiple-choice check questions 
PDF1 questions for reflection 
PDF2 decisional balance worksheet 
PDF3 treatment goal setting worksheet 
PDF4 summary of M2  
Videos 1–4. Objectives of the module; what are emotions?; the adaptive role of emotions; the 
three-component model of emotions; 
Multiple-choice check questions 
PDF1 the function of emotions 
PDF2 three component model of emotions worksheet 
PDF3 summary of M2 
S2 Part 1 (30′):   
– Presentation of the agenda  
– Doubts and questions about M1 
to M3  
– Emphasis on self-monitoring, 
practice and homework 
Part 2 (90′):   
– Presentation of M4 and M5 
M4. The acceptance of emotional 
experiences 
M5. Practicing acceptance 
Videos 1–5. Objectives of the module; primary and secondary emotional response; present- 
focused emotional awareness; observe the breath; the five senses exercise 
Multiple-choice check questions 
PDF1 “what” techniques 
PDF2 “how” techniques 
PDF3 summary of M4  
Videos 1–4. Objectives of the module; present-focused awareness of physical sensations; 
present-focused awareness of thoughts; present-focused awareness of emotions 
Multiple-choice check questions 
PDF1 present-focused awareness of physical sensations worksheet 
PDF2 present-focused awareness of thoughts worksheet 
PDF3 present-focused awareness of emotions worksheet 
PDF4 present-focused awareness of the daily life worksheet 
PDF5 web links with videos to practice present-focused awareness of emotions 
PDF6 summary of M5 
S3 Part 1 (30′):   
– Presentation of the agenda  
– Doubts and questions about M4 
and M5  
– Emphasis on self-monitoring, 
practice and homework 
Part 2 (90′):   
– Presentation of M6 and M7 
M6. Learning to be flexible 
M7. Practicing cognitive 
flexibility 
Videos 1–8. Objectives of the module; cognitive appraisal; how interpretations influence 
emotions; how the same situation can be interpreted in different ways; how emotions 
influence interpretations; negative thoughts (catastrophizing); downward arrow technique; 
identification and reappraisal of automatic thoughts (example) 
Multiple-choice check questions 
PDF1 downward arrow technique worksheet 
PDF2 identification and reappraisal of automatic thoughts worksheet 
PDF3 summary of M6  
Videos 1–5. Objectives of the module; cognitive reappraisal; techniques for cognitive 
reappraisal; strategies for the reappraisal of automatic thoughts (example); evaluating 
obsessive, intrusive, nonsensical thoughts 
Multiple-choice check questions 
PDF1 strategies for the reappraisal of automatic thoughts worksheet 
PDF2 identification and reappraisal of automatic thoughts worksheet 
PDF3 downward arrow technique worksheet 
PDF4 identification and reappraisal of automatic thoughts worksheet 
PDF5 summary of M7 
S4 Part 1 (30′):   
– Presentation of the agenda  
– Doubts and questions about M6 
and M7  
– Emphasis on self-monitoring, 
practice and homework 
Part 2 (90′):   
– Presentation of M8 and M9 
M8. Emotional avoidance 
M9. Emotion-driven behaviors 
Videos 1–3. Objectives of the module; types of maladaptive emotional regulation strategies; 
consequences of maladaptive emotional regulation strategies 
Multiple-choice check questions 
PDF1 maladaptive emotional regulation strategies worksheet 
PDF2 consequences of emotional avoidance worksheet 
PDF3 emotional avoidance strategies worksheet 
PDF3 summary of M8  
Videos 1–3. Objectives of the module; emotion-driven behaviors; the opposite action 
Multiple-choice check questions 
PDF1 emotion-driven behaviors worksheet 
PDF2 the opposite action 
PDF3 Summary of M9 
S5 Part 1 (30′):   
– Presentation of the agenda  
– Doubts and questions about M8 
and M9 
M10. Accepting and facing 
physical sensations 
M11. Facing emotions in the 
contexts where they occur 
Videos 1–3. Objectives of the module; the role of physical sensations in emotion; the 
avoidance of physical sensations 
Multiple-choice check questions 
PDF1 exercises to generate physical sensations 
PDF2 symptoms associated with the different exercises 
(continued on next page) 
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quality of life. The QLI has shown high test-retest reliability (r = 0.87). 
The Spanish version of the QLI has shown good internal consistency (α 
= 0.87) and test-retest reliability in a clinical sample (Mezzich et al., 
2000). 
Work and Social Adjustment Scale (WSAS) (Mundt et al., 2002). The 
WSAS is a 5-item scale that evaluates the degree of interference asso-
ciated with the patients’ symptoms in the following five domains: work, 
home management, private leisure, social leisure, and family relation-
ships. Items are coded on a scale from 0 (not at all) to 8 (very severely), 
and higher scores are indicative of greater interference in the different 
areas. The scale has shown good to excellent internal consistency (α =
0.70 to 0.94), test-retest reliability, and sensitivity to change. The 
Spanish version has demonstrated excellent internal consistency and 
good concurrent validity (Echezarraga et al., 2018). 
2.5.2. Treatment acceptability 
2.5.2.1. Expectations and opinion of treatment. Expectations and opinion 
of treatment scales (Borkovec and Nau, 1972). Each scale contains 5 
items rated from 0 (“nothing at all”) to 10 (“completely”). The expec-
tation scale is applied after the treatment rationale has been explained. It 
aims to assess subjective patient expectations about this treatment. The 
opinion scale is administered after the patient has completed the treat-
ment, and its objective is to evaluate the patient’s satisfaction with this 
treatment. The items cover how logical the treatment is (“How logical do 
you think this treatment is?”), the degree of satisfaction with the 
treatment (“How satisfied are you with the treatment?”), whether the 
patient would recommend it to a person with similar problems (“To 
what extent do you feel confident recommending this treatment to a 
friend who has the same problems?”), how useful the treatment would 
be in treating other psychological problems (“To what extent do you 
think this treatment could be useful in treating other psychological 
problems?”), and how useful the treatment is for the patient (“To what 
extent do you think this treatment will be/was helpful to you?”).Our 
team has used this scale in a number of research studies (Botella et al., 
2009, 2016; Campos et al., 2018; Mira et al., 2017). 
2.5.2.2. Satisfaction with the group sessions. In order to evaluate the 
participant’s satisfaction with each of the different face-to-face group 
sessions, an ad hoc questionnaire was developed with seven questions 
rated on a Likert scale. The questions, rated from 0 (not at all) to 10 
(extremely), include the following: 1) How helpful do you think the 
contents of this session can be for your problems?; 2) How useful do you 
think the contents of this session can be for your psychological problems 
at other times in your life?; 3) How logical do the contents of this session 
seem to you?; 4) How difficult/boring do the contents of this session 
seem to you?; 5) How interesting/enjoyable do the contents of this 
session seem to you?; 6) How clear/understandable were the contents of 
this session to you?; and 7) What overall score would you give the 
session? 
Table 1 (continued ) 
Sessions Group session Modules Multimedia elements  
– Emphasis on self-monitoring, 
practice and homework 
Part 2 (90′):   
– Presentation of M10 and M11 
PDF3 symptom induction test worksheet 
PDF4 interoceptive exposure self-monitoring worksheet 
PDF5 summary of M10  
Videos 1–4. Objectives of the module; what is graded exposure?; Situational exposure; 
exposure in the imagination 
Multiple-choice check questions 
PDF1 emotional exposure hierarchy worksheet 
PDF2 exposure self-monitoring worksheet 
PDF3 summary of M11 
S6 Part 1 (30′):   
– Presentation of the agenda  
– Doubts and questions about M10 
and M11  
– Emphasis on self-monitoring, 
practice and homework 
Part 2 (90′):   
– Presentation of M12 and M13 
M12. Learning to move on 
M13. Learning to enjoy 
Videos 1–6. Objectives of the module; the relationship between inactivity and emotional 
distress; how being active can improve emotional well-being; the importance of short- and 
long-term significant life goals; the role of social support in emotional well-being; difficulties 
with and recommendations for behavioral activation 
Multiple-choice check questions 
PDF1 recommendations for setting short- and long-term significant life goals 
PDF2 activity planning and social support form 
PDF3 diary of daily activities form 
PDF4 summary of M12  
Videos 1–5. Objectives of the module; the role of positive emotions in life; the induction of 
positive emotions; the importance of smiling; exercise: smile to others 
Multiple-choice check questions 
PDF1 summary of M13  
Table 2 
Study variables and assessment times.  
Measure Area of assessment Time of 
assessment 
Diagnostic interview 
MINI Psychiatric diagnosis BL  
Primary outcomes 
OASIS Severity of anxiety BL, post-M, post-T 
and FU 
ODSIS Severity of depression BL, post-M, post-T 
and FU  
Secondary outcomes 
PANAS Positive and negative affect BL, post-M, post- 
T, FU, 
NEO-FFI Neuroticism and extraversion BL, post-T and FU 
QLI Quality of life BL, post-T and FU 
WSAS Work and social adjustment BL, post-T and FU 
Expectations 
scale 
Expectations of treatment BL 
Opinion scale Opinion of treatment Post-T 
Satisfaction scale Satisfaction with group sessions Post-F2F group 
sessions 
SUS Usability of the program Post-T 
Platform usage 
indicators 
Number of modules completed, number 
of logins, number of times each module 
has been accessed/reviewed 
Throughout the 
study period 
Note. MINI: MINI Neuropsychiatric Interview; BL: Baseline; OASIS: Overall 
Anxiety Severity and Impairment Scale; Post-M: Post-module; Post-T: Post- 
treatment; FU: Follow-up; ODSIS: Overall Depression Severity and Impairment 
Scale; PANAS: Positive and Negative Affect Schedule; NEO-FFI: NEO Five Factor 
Inventory; QLI: Quality of Life Inventory; WSAS: Work and Social Adjustment 
Scale; F2F: Face-to-face; SUS: System Usability Scale. 
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2.5.2.3. Usability of the program. The System Usability Scale (SUS) 
(Bangor et al., 2008; Brooke, 1996) is applied in order to assess the 
usability of a service or product and the acceptance of technology by the 
people who use it. The SUS is a simple, ten-item scale that indicates the 
degree of agreement or disagreement with the statements on a 5-point 
scale (1 = strongly disagree; 5 = strongly agree). The final score is ob-
tained by adding the scores on each item and multiplying the result by 
2.5. Scores range from 0 to 100, where higher scores indicate better 
usability. 
2.5.3. Other outcome measures 
2.5.3.1. Assessment of barriers and facilitators. A focus group method 
will be used in order to obtain a wider range of answers and greater 
detail about the participants’ opinions of the treatment, the face-to-face 
sessions, and the online platform. This methodology involves the use of 
in-depth questions about a given topic in a dynamic group with the aim 
of providing abundant information about the perspectives, perceptions, 
opinions, feelings, and thoughts individuals have about a certain issue, 
in this case, a blended group transdiagnostic treatment (Krueger and 
Casey, 2000). For this purpose, with the participants’ consent, we will 
record the focus group interviews on audiotapes, and we will conduct 
qualitative data analyses. Specifically, we will use the Consensual 
Qualitative Research (CQR) methodology to gather information within 
certain thematic areas and subsequent domains (Hill et al., 2005). CQR 
was developed by psychotherapy researchers, and there is a data anal-
ysis protocol with a clear explanation about how to analyze the raw data 
(McLeod, 2013). 
2.5.3.2. Online platform usage measures. Participants’ engagement and 
use of the online treatment platform will be assessed using several 
measures collected by the online system. These data will include infor-
mation such as the total number of modules completed, the number of 
days spent in each module, the number of times each module was 
accessed (i.e., every time the user logs on to the platform), and the 
number of times each module was reviewed. 
The study variables and assessment times are summarized in Table 2. 
3. Ethics and dissemination 
The trial has received ethical approval from the Ethics Committee of 
Universitat Jaume I (September 2019) and will be conducted in accor-
dance with the study protocol, the Declaration of Helsinki, and good 
clinical practice. All participants will be volunteers, and they will sign a 
written, informed consent before their participation in the study. The 
security and confidentiality of the data will be guaranteed, i.e., all 
transferred data will be secured via AES-256 encryption (Advanced 
Encryption Standard). The web platform will be accessed through a 
unique username-password combination that will be available on a 24/7 
basis. Only participants will have access to their password. In order to 
protect patients’ privacy, sensitive information, i.e., personal data, will 
be replaced by codes and stored separately from clinical data (e.g. 
clinical outcomes). Only researchers directly involved in the current 
study will have access to these data. The results of this study will be 
disseminated by presentation at conferences and will be submitted for 
publication in a peer-reviewed journal. 
4. Data analysis plan 
Because the goal of this study is to analyze the feasibility of a blended 
transdiagnostic group intervention for ED, the analysis will be per-
formed through descriptive statistics rather than formal hypothesis 
testing. To preliminary estimate the impact of the intervention, means, 
standard deviations, effect sizes and their corresponding confidence 
intervals will be calculated for both principal and secondary measures. 
The software SPSS version 26.0 will be used to conduct these analyses. 
Finally, qualitative data analyses will be conducted following the 
COnsolidated criteria for REporting Qualitative research (COREQ) 
(Tong et al., 2007). 
5. Discussion 
This study investigates the feasibility of a novel, blended (face-to- 
face and Internet-delivered therapy), group intervention for the regu-
lation of emotional disorders. First, we aim to study the adequacy of the 
recruitment and data collection processes (e.g. whether inclusion and 
exclusion criteria should be adjusted; patients’ willingness to participate 
in the trial). Second, another goal is to explore the reasons of patients 
that refuse to participate (e.g., the patient prefers an individual format). 
Relatedly, compliance with both the treatment and assessment pro-
tocols, retention and attrition rates, as well as reasons for drop out will 
be studied. Therefore, the psychometric data obtained in this trial will be 
helpful to define the assessment protocol in anticipation of a future RCT. 
Finally, both quantitative (i.e., expectations and opinion of treatment, 
usability of the treatment platform) and qualitative data (i.e., interviews 
about participants’ opinions) will be collected and analyzed. In our own 
experience as clinical researchers, qualitative analysis procedures can 
provide critical data to improve the design and development of clinical 
trials (Fernández-Álvarez et al., 2017). On the other hand, this study 
seeks to preliminary estimate the impact of the intervention in a number 
of clinical measures at post-treatment and 3-month follow up. Taken 
together, these objectives will help to optimize the design of a future 
RCT. The present study seeks to contribute to solving some of the 
challenges in the mental health field, specifically to transform the 
healthcare system and policy responses in order to disseminate and 
implement evidence-based treatments (EBTs) around the world (Collins 
et al., 2011) and provide psychological support to all those in need 
(Kazdin, 2015). In line with this, the intervention described in this study 
combines the advantages of transdiagnostic treatments for emotional 
disorders (better management of comorbid presentations, higher cost- 
effectiveness, and dissemination) (Mansell et al., 2009; McEvoy et al., 
2009; Sauer-Zavala et al., 2017) and Internet-delivered treatments 
(accessibility, versatility, and anonymity) (Andrews et al., 2010; 
Richards and Richardson, 2012; Spek et al., 2007). 
Although Internet-delivered treatments are generally effective for 
depression and anxiety disorders, not all patients benefit from this 
treatment delivery format equally (e.g., patients who need more per-
sonal contact or those less likely to benefit from Internet-delivered 
treatments) (Fernández-Álvarez et al., 2017). Consequently, face-to- 
face therapy remains an important aspect of mental healthcare. 
Blended interventions have been developed to cover the research pri-
ority of delivering cost-effective interventions. It is not surprising, 
therefore, that combining these two approaches (i.e., face-to-face and 
Internet-delivered treatments) into one integrated treatment may be a 
way to take advantage of the best aspects of these two treatment mo-
dalities (Kooistra et al., 2014; Van der Vaart et al., 2014; Wentzel et al., 
2016). Nevertheless, research on blended interventions has focused 
primarily on individual therapy, and less attention has been paid to the 
potential of using this format in group psychotherapy and, more spe-
cifically, in group transdiagnostic treatments, which have already 
shown their efficacy in several RCTs (Norton, 2012; Reinholt et al., 
2017). Adding the group format intervention to a transdiagnostic 
treatment for emotional disorders and delivering it in a blended therapy 
format could contribute to some of the research priorities, such as the 
implementation of EBTs and the dissemination and sustainability of 
mental health promotion (Forsman et al., 2015; Wykes et al., 2015). 
Despite the existence of effective evidence-based treatments, their 
transfer to routine practice is often quite scarce (Cunningham et al., 
2010; Grimshaw et al., 2012). Specifically, the implementation of 
blended therapy combining face-to-face and Internet-delivered in-
terventions is still limited. The use of blended therapy may depend on its 
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clinical effectiveness, but also on its acceptance by patients undergoing 
the treatment. In this regard, knowledge about barriers and facilitators 
in the implementation of a blended therapy from the patients’ 
perspective seems to be essential. A qualitative approach (focus group) 
will be followed to explore this aspect. 
In summary, this feasibility study presents a user-centered blended 
group intervention for the treatment of emotional disorders. To the best 
of our knowledge, this is the first study to investigate the feasibility of a 
blended group transdiagnostic treatment in patients with emotional 
disorders. 
We are aware that this study has limitations. On the one hand, the 
trial has no control group, and so no conclusions can be drawn about the 
clinical efficacy of the intervention. The selection of an adequate control 
group (e.g., advantages and disadvantages of different types of control 
group) will be carefully considered when planning the future RCT. 
However, the aim of this study is to gain insight into the implementation 
value of a transdiagnostic group blended treatment, rather than its 
clinical effectiveness. On the other hand, because face-to-face sessions 
take place once every 3 weeks, some patients’ use of the online platform 
might be lower than expected. To mitigate this, we developed a support 
protocol that includes automatized emails and text messages (e.g., with 
reminders about the importance of doing the homework tasks, prac-
ticing the different strategies, and so on). 
The results of this study will provide data on the acceptability and 
feasibility of a transdiagnostic blended treatment for patients with 
emotional disorders. Furthermore, it will facilitate knowledge acquisi-
tion and open up new forms of patient-to-patient or patient-to-therapist 
communication. This will provide valuable data about the way patients 
use the program modules, the frequency and duration with which they 
enter them, the opinion about each of them, and the adherence to the 
program. This study may help to consider the utility of feasibility studies 
in practice, with the aim of better understanding the way an interven-
tion works and facilitating ongoing adaptation of the treatment and 
assessment design in preparation for a randomized controlled trial of a 
blended transdiagnostic group treatment for emotional disorders. 
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González-Robles, A., Díaz-García, A., Miguel, C., et al., 2018a. Comorbidity and 
diagnosis distribution in transdiagnostic treatments for emotional disorders: a 
systematic review of randomized controlled trials. PloSOne 13 (11), e0207396. 
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